Skip to main content
. 2012 Dec 19;7(12):e45817. doi: 10.1371/journal.pone.0045817

Table 1. The protein targets and the antigens used in the study.

Gene Description Mw for protein target (kDa) No of aa for antigen No of immunizations Epitope mapping
1. HNRNPH2 Heterogeneous nuclear ribonucleoprotein H2 49,3 115 3 (2) SP+BD
2. SYNJ2BP Synaptojanin 2 binding protein 15,9 112 3 SP+BD
3. RPS6KA5 Ribosomal protein S6 kinase, 90 kDa, polypeptide 5 89,9 136 3 SP+BD
4. ERBB2 Erythroblastic leukemia viral oncogene homolog 2 (Her2) 137,9 96 3 SP+BD
5. TYMP Thymidine phosphorylase 50,4 125 3 SP+BD
6. PDXP Pyridoxal (vitamin B6) phosphatase 31,7 137 3 SP+BD
7. FBXO28 F-box protein 28 41,1 101 3 BD
8. C22orf29 Chromosome 22 open reading frame 29 39,3 125 3 BD
9. FOXP2 Forkhead box P2 79,9 104 3 BD
10. IL17RA Interleukin 17 receptor A 96,1 128 3 BD

Gene name and description of protein targets are listed as denoted by ENSEMBL. The molecular weight (kDa) of the protein target is shown. If several splice variants, the isoform with the largest molecular weight is shown. Further, the number of amino acids of the antigen (PrEST) is shown. The number of immunizations and the method of epitope mapping used in each cases is finally listed, with SP representing synthetic peptides using the suspension bead array method and BD representing bacterial surface display using gene fragment expressed on the surface of Staphyloccoccus carnosus cells.